Phase 4 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with invasive breast cancer, confirmed by a laboratory tissue test.
- People whose doctors have recommended a chemotherapy treatment plan that includes a type of drug called anthracyclines, either before or after surgery.
- People whose kidneys are working at a sufficient level (confirmed by a blood test measuring kidney function).
- People whose heart is pumping at a healthy rate, with a heart pumping strength measurement above 50%.
- People aged between 18 and 60 years old.
Who may not be able to join:
- People who have an existing heart condition that makes anthracycline chemotherapy unsafe to use, such as heart failure, irregular heartbeat, stroke, or a previous heart attack.
- People who have previously been treated with anthracycline-based chemotherapy or any other chemotherapy known to affect the heart.
- People who are currently pregnant or breastfeeding.
- People who are currently taking other medications known to be harmful to the heart.
- People who have a condition called diabetic ketoacidosis, or who have been diagnosed with type 1 diabetes.
- People who have had radiation treatment directed at the chest area that included the heart.
- People who are not willing to sign the required consent form agreeing to take part in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201115817090
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
N-terminal pro-B-type natriuretic peptide (NT-pro BNP) testing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.